Bearish flow noted in Iovance Biotherapeutics with 2,318 puts trading, or 1.9x expected. Most active are Sep-24 11 puts and 8/30 weekly 11.5 calls, with total volume in those strikes near 2,200 contracts. The Put/Call Ratio is 3.53, while ATM IV is up nearly 18 points on the day. Earnings are expected on November 5th.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IOVA:
- Iovance Biotherapeutics call volume above normal and directionally bullish
- Iovance Biotherapeutics ‘pretty attractive long idea,’ says Martin Shkreli
- Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
- Biotech Alert: Searches spiking for these stocks today
- Iovance Biotherapeutics price target lowered to $24 from $26 at Baird